News Release

Dying from a food allergy is less likely than being murdered

Peer-Reviewed Publication

Imperial College London

A person with a food allergy is more likely to be murdered than to die from a severe reaction, according to a new study.

One in 10 children has a food allergy. Many sufferers and their parents experience anxiety about the possibility of a severe and life-threatening allergic reaction, called anaphylaxis, but until now no studies have estimated how common death from such reactions is. Based on data from 13 studies worldwide, researchers at Imperial College London calculated that for any person with a food allergy, the chance of dying from anaphylaxis in one year is 1.81 in a million. For children and young people aged 0-19, the risk is 3.25 in a million.

By comparison, in Europe the risk of being murdered is 11 in a million and of dying from accidental causes is 324 in a million over a year (US figures in notes to editors).

Dr Robert Boyle, from the Department of Medicine at Imperial, who led the study, said: "Everyone has heard stories of people who have died suddenly from a severe allergic reaction, and these stories are frightening. But events like this appear to be very rare, and it's helpful to put that risk in perspective.

"We don't want to belittle the concerns of people with food allergies or their families, and of course people should continue to take reasonable precautions. That said, we want to reassure them that having a food allergy makes a very small difference to someone's overall risk of death.

"Worrying about severe allergic reactions can take a huge toll on someone's quality of life. We should address anxiety and quality of life for food allergic people and their carers, rather than just focus on the risk of death."

The study is published in Clinical and Experimental Allergy. It was funded by Lincoln Medical and the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre.

Food allergies appear to be becoming more common. Hospital admissions for children with food allergies have risen five times in the last 20 years, but the reason for this trend is unclear.

Typical allergic reactions involve swelling, rash, or eczema. The reason why severe, life-threatening reactions sometimes occur is not known. The dose of allergen plays a role in determining the risk, but the dose required to trigger anaphylaxis varies widely. Anaphylaxis is most common in young people, but doctors have no way to tell which patients are most susceptible.

###

For more information please contact:

Sam Wong
Research Media Officer
Imperial College London
Email: sam.wong@imperial.ac.uk
Tel: +44(0)20 7594 2198
Out of hours duty press officer: +44(0)7803 886 248

Notes to editors

1. In the US, the risk of being murdered is 61 in a million and of dying from accidental causes is 399 in a million over a year.

2. The risks given above for accidental death and murder are for all ages. For children aged 0-19, the risk of accidental death in one year is 73.9 in a million in Europe or 141 in a million in USA. The risk of murder in one year is 3.82 in a million in Europe or 40 in a million in USA.

3. Journal reference: T. Umasunthar et al. 'Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis.' Clinical and Experimental Allergy, Volume 43, Issue 12, pages 1333, December 2013. dx.doi.org/10.1111/cea.12211.

4. About Imperial College London

Consistently rated amongst the world's best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 14,000 students and 6,000 staff of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture. Since its foundation in 1907, Imperial's contributions to society have included the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of research for the benefit of all continues today, with current focuses including interdisciplinary collaborations to improve global health, tackle climate change, develop sustainable sources of energy and address security challenges.

In 2007, Imperial College London and Imperial College Healthcare NHS Trust formed the UK's first Academic Health Science Centre. This unique partnership aims to improve the quality of life of patients and populations by taking new discoveries and translating them into new therapies as quickly as possible.

Website: http://www.imperial.ac.uk

5. About the NIHR

The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research. Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has increased the volume of applied health research for the benefit of patients and the public, driven faster translation of basic science discoveries into tangible benefits for patients and the economy, and developed and supported the people who conduct and contribute to applied health research. The NIHR plays a key role in the Government's strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, programmes, centres of excellence and systems represent the most integrated health research system in the world. For further information, visit the NIHR website.

6. About NIHR Biomedical Research Centres

NIHR Biomedical Research Centres support research across a wide range of disease areas. These Centres are the most outstanding NHS/University research partnerships in the country; leaders in scientific translation and early adopters of new insights in technologies, techniques and treatments for improving health. To ensure they are able to succeed, the NIHR BRCs receive substantial levels of sustained funding. NIHR BRC funding supports the NHS infrastructure to create an environment where scientific endeavour can thrive, attracting the foremost talent and producing world-class outputs.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.